DepressionMental HealthPharmacologyStrictly Clinical

Treatment-resistant depression and the T-rex combination

Share
Download PDF
By: Gryan Garcia, PhD, PsyD, FNP-BC, PMHNP-BC; Christy Cotner, DNP, FNP-C, PMHNP-BC; and Robert Spano, DNP, FNP-C, PMHNP-BC

The T-Rex combination of Trintellix (vortioxetine) and Rexulti (brexpiprazole) targets multiple neurotransmitter systems, providing a novel and effective approach for managing treatment-resistant depression.

This article is available to American Nurses Association members and ANJ subscribers only.
Already a member? Log in here

Let Us Know What You Think

Test Your Knowledge

In what way does emotional intelligence affect nursing leaders in team and patient care settings?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts